Neuroscience

AI Model Predicts Alzheimer’s Using Speech Analysis

Debi Johnson

Summary: can predict whether someone with mild cognitive impairment will develop Alzheimer’s disease with 78.5% accuracy by analyzing speech. This ...

AI Voices Fool Humans, But Brain Responses Differ

Daisy Hips

Summary: People struggle to distinguish between human and AI-generated voices, identifying them correctly only about half the time. Despite this, ...

Hippocampus Distinguishes Urgent from Future Goals

Daisy Hips

Summary: Researchers discovered how the brain prioritizes immediate and distant goals. Their study found that the hippocampus processes urgent goals ...

Tailoring Magnetic Stimulation for Depression

Debi Johnson

Summary: Researchers reveal how targeting transcranial magnetic stimulation (TMS) could enhance treatment for depression. The study identified an electrophysiological marker ...

Mindfulness Improves Sleep and Reduces Stress

Debi Johnson

Summary: A new study reveals that mindfulness helps improve sleep quality and reduce stress by focusing on the present and ...

New Peptide Treatment Reverses Cognitive Decline

Debi Johnson

By Okinawa Institute of Science and Technology (OIST) Graduate University June 23, 2024 Alzheimer’s disease, a progressive neurodegenerative disorder affecting ...

Resilience Linked to Healthier Brain and Gut

Debi Johnson

Summary: A new study reveals that resilient individuals show improved brain function and healthier gut microbiomes. The research highlights that ...

Ozempic May Reduce Alzheimer’s Risk

Debi Johnson

Summary: GLP-1 agonists like Ozempic reduce the risk of dementia in type 2 diabetes patients. The research followed over 88,000 ...

ALS Study Reveals Subtypes and Promising Drug Target

Debi Johnson

Summary: Researchers identified four subtypes of ALS, which could lead to more effective, personalized treatments. The study also highlights significant ...

Synthetic Peptide Reverses Alzheimer’s Symptoms

Debi Johnson

Summary: Researchers reversed Alzheimer’s symptoms in mice using a synthetic peptide, PHDP5, that targets brain function. The study shows that ...

12352 Next